Thames Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$9.09M |
| 2 |
NVIDIA
NVDA
|
+$5.35M |
| 3 |
Uber
UBER
|
+$5.31M |
| 4 |
Workday
WDAY
|
+$4.58M |
| 5 |
Liberty Media Series C
FWONK
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$8.69M |
| 2 |
Entegris
ENTG
|
+$3.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 58.59% |
| 2 | Financials | 16.99% |
| 3 | Communication Services | 7.31% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Industrials | 4.5% |
Similar funds
Thames Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Thames Capital Management held 25 positions worth $188M, up 32% from $142M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Thames Capital Management deployed $26.9M of net new capital in Q2 2023, opening 6 new positions and adding to 5 existing holdings. Its largest new stake was Meta Platforms (Facebook): 36,847 shares worth $10.6M.
By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 57% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Entegris, an estimated $3.71M trimmed.
- Thames Capital Management's largest Q2 2023 buy was Meta Platforms (Facebook): 36,847 shares worth $10.6M.
- Thames Capital Management added most to Salesforce in Q2 2023, an estimated $3.02M increase.
- Thames Capital Management's biggest Q2 2023 reduction was Entegris, cutting an estimated $3.71M.
- Thames Capital Management fully exited Bio-Rad Laboratories Class A in Q2 2023, selling an estimated $8.69M.
- Thames Capital Management's ten largest holdings make up 66% of its $188M portfolio in Q2 2023.
- Thames Capital Management opened 6 new positions and closed 1 in Q2 2023.
- Thames Capital Management's portfolio value rose 32% quarter-over-quarter to $188M.
Based on Thames Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.